Skip to content
lifestyle.ketodash.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aimwell Partners
AimwellBio Secures Proprietary Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors
August 17, 2026
AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency
August 13, 2026
Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million
August 6, 2026
The World’s Most Valuable Healthcare Database May Already Exist, The Problem Is Nobody Knows Who to Trust Inside It
July 27, 2026
AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup
June 29, 2026
AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape
May 21, 2026
AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings
May 20, 2026
Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure
April 29, 2026
Aimwell Bio Announces “Founding Cohort” of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma
April 20, 2026
AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio
April 15, 2026